Publication | Closed Access
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
105
Citations
38
References
2024
Year
Surgical OncologyHepatologyMedicinePathologyLiver DiseaseAdjuvant SintilimabLiver CancerCancer TreatmentPhase 2OncologyRadiation OncologyHepatocellular CarcinomaCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1